A thorough and independent investigation conducted by external legal counsel has found no evidence of wrongdoing by founder and board member Dean Kamen. The comprehensive review examined matters relevant to recent DOJ disclosures.
Based on the independent investigation’s conclusion, Dean Kamen will resume his full participation on the ARMI Board of Directors and will continue to play a vital role in ARMI’s mission to advance the U.S. bioeconomy and transform the future of human health.
